title: Reimbursement of pharmaceuticals in New Zealand: comments on PHARMAC's processes.
authors: The National Heart Foundation, Pharmaceutical Advisory Committee, Auckland. boyds@nhf.org.nz
authors: B
authors: B
authors: Swinburn
authors: R J
authors: RJ
authors: Milne
authors: M
authors: M
authors: Richards
authors: E
authors: E
authors: Begg
authors: S
authors: S
authors: Foote
authors: R
authors: R
authors: Jackson
mesh_terms: D002317:Cardiovascular Agents / Q000191:economics; D003363:Cost Control; D003362:Cost-Benefit Analysis; D003659:Decision Making, Organizational; D019317:Evidence-Based Medicine; D005252:Fees, Pharmaceutical; D006801:Humans; D007349:Insurance, Health, Reimbursement; D007356:Insurance, Pharmaceutical Services / Q000191:economics*; D009520:New Zealand; D011907:Rate Setting and Review / Q000379:methods* / Q000458:organization & administration; D018570:Risk Assessment
chemical_list: D002317:Cardiovascular Agents